Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
265 articles
Researchers modified red blood cells to teach the immune system tolerance, potentially ending need for harsh immunosuppressive drugs.
Revolutionary precision immunotherapies use AI and cellular engineering to target lupus at its source, offering hope for durable remission.
HSCT therapy achieves drug-free remission in patients with treatment-resistant autoimmune conditions like lupus and rheumatoid arthritis.
Revolutionary cancer treatment successfully treats treatment-resistant autoimmune disease, offering hope for severe cases.
Breakthrough treatments targeting specific immune pathways show promise for reducing steroid dependence in EGPA patients.
New antigen-specific tolerance approach could treat multiple sclerosis and related diseases without broad immunosuppression.
Researchers reveal the immune mechanisms behind uveitis, a leading cause of preventable blindness, opening doors to targeted therapies.
New research reveals how two common endocrine conditions interact to disrupt fertility, pregnancy, and menopause in women.
Breakthrough therapy targeting B cells demonstrates significant improvement in lupus symptoms with sustained benefits over one year.
Chinese researchers test safer alternative to CAR-T therapy for lupus patients, achieving remission in 67% with minimal side effects.
New analysis reveals comparable effectiveness between JAK inhibitors and biological therapies for rheumatoid arthritis patients.
Study reveals how specific antibodies affect tolerance to different rheumatoid arthritis medications, offering personalized treatment insights.
